Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non–ST-segment elevation acute coronary syndromes
- 15 February 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (4), 448-451
- https://doi.org/10.1016/s0002-9149(02)03244-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndromeThe American Journal of Cardiology, 2000
- Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiograThe American Journal of Cardiology, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial InfarctionCirculation, 1999
- Early diagnosis of acute myocardial infarction in patients without ST-segment elevationThe American Journal of Cardiology, 1999
- Very Early Risk Stratification Using Combined ECG and Biochemical Assessment in Patients With Unstable Coronary Artery Disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] Substudy)Circulation, 1998
- Management of Acute Coronary Syndromes Based on Risk Stratification by Biochemical MarkersCirculation, 1998
- Cardiac troponins: IT upgrade for the heartThe Lancet, 1998
- Value of Myoglobin, Troponin T, and CK-MB mass in Ruling Out an Acute Myocardial Infarction in the Emergency RoomCirculation, 1995
- New Serum Markers for Acute Myocardial InfarctionNew England Journal of Medicine, 1994